A novel immune-related prognostic signature based on Chemoradiotherapy sensitivity predicts long-term survival in patients with esophageal squamous cell carcinoma.
PeerJ（2023）
摘要
The above results may provide guidance for developing novel treatment and prognostic strategies in ESCC patients.
更多查看译文
关键词
Chemoradiotherapy sensitivity,Differential expression genes,Esophageal squamous cell carcinoma,Interleukins,Neoadjuvant chemoradiotherapy,Prognosis,Signaling pathway
AI 理解论文
溯源树
样例
生成溯源树，研究论文发展脉络
Chat Paper
正在生成论文摘要